Cutera, Inc.

Equities

CUTR

US2321091082

Advanced Medical Equipment & Technology

Market Closed - Nasdaq Other stock markets 04:00:00 2024-04-26 pm EDT			5-day change	1st Jan Change
2.12 ^USD	+3.92%		+8.72%	-39.86%

Apr. 11	Cutera, Inc. Announces North America Launch of xeo+	CI
Mar. 25	North American Morning Briefing : Tech in Focus on -2-	DJ

Cutera, Inc. Provides Earnings Guidance for the Full Year 2023

November 08, 2023 at 04:01 pm EST

Cutera, Inc. provided earnings guidance for the full year 2023. The Company expects full-year 2023 revenue of approximately $205 million and ending 2023 cash and marketable securities of approximately $135 million.

Latest news about Cutera, Inc.

Cutera, Inc. Announces North America Launch of xeo+	Apr. 11	CI
North American Morning Briefing : Tech in Focus on -2-	Mar. 25	DJ
Sector Update: Health Care Stocks Ease Late Afternoon	Mar. 22	MT
Sector Update: Health Care	Mar. 22	MT
Cutera Shares Fall After Q4 Loss Widens, Revenue Drops	Mar. 22	MT
William Blair Upgrades Cutera to Market Perform From Underperform	Mar. 22	MT
Wall Street Set to Open Marginally Lower Friday Following Powell Speech, After Hitting Record Highs Thursday	Mar. 22	MT
North American Morning Briefing : Stocks Struggle After New Records	Mar. 22	DJ
Stocks to Watch : FedEx, Lululemon Athletica, Cutera	Mar. 21	DJ
Transcript : Cutera, Inc., Q4 2023 Earnings Call, Mar 21, 2024	Mar. 21
Earnings Flash (CUTR) CUTERA Reports Q4 Revenue $49.5M, vs. Street Est of $47.5M	Mar. 21	MT
Cutera, Inc. Provides Revenue Guidance for the Full Year 2024	Mar. 21	CI
Cutera, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	Mar. 21	CI
North American Morning Briefing : Investors -2-	Mar. 21	DJ
Cutera, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Mar. 05	CI
Cutera's Preliminary Full-Year Revenue Tops Estimates; Shares Rise	Jan. 09	MT
Cutera, Inc. Revises Revenue Guidance for the Full Year 2023	Jan. 09	CI
Cutera Receives Non-Compliance Notice From Nasdaq	Nov. 17	MT
Cutera Fails to File Q3 Report on Form 10-Q on Inventory Accounting Issue	Nov. 14	MT
Cutera, Inc. Appoints Stephana Patton as Chief Legal Officer	Nov. 13	CI
Transcript : Cutera, Inc., Q3 2023 Earnings Call, Nov 08, 2023	Nov. 08
Earnings Flash (CUTR) CUTERA Reports Q3 Revenue $46.5M, vs. Street Est of $52.7M	Nov. 08	MT
Cutera, Inc. Provides Earnings Guidance for the Full Year 2023	Nov. 08	CI
Cutera, Inc. Announces Consolidated Preliminary Revenue Result for the Third Quarter of 2023	Nov. 08	CI
Cutera, Inc. Announces Resignation of Juliane Park from the Board of Directors, Effective as of December 1, 2023	Nov. 07	CI

Chart Cutera, Inc.

Duration

Period

More charts

Company Profile

Cutera, Inc. develops, manufactures, distributes, and markets energy-based product platforms for medical practitioners, enabling them to offer treatments to their customers. The Company distributes third-party manufactured skincare products and secret systems and consumables. Its system platforms include AviClear, enlighten, excel, truSculpt, Secret PRO, Secret RF, and xeo. The Companyâs Cutera Core segment consists of the Companyâs systems, consumables, skincare, and service businesses. The Cutera Core segment develops, distributes and manufactures energy-based systems for medical practitioners in addition to distributing third-party manufactured skincare products in Japan. The Companyâs AviClear segment consists of the AviClear business. The Companyâs acne solution, AviClear, is a prescription-free, drug-free laser treatment for the treatment of mild to severe acne. Its products include CUTERA, ACUTIP 500, AVITM, AVI360, AVIANALYTICSTM, AVICARE COOLGLIDE, and more.

Sector

Advanced Medical Equipment & Technology

Calendar

2024-05-09 - Q1 2024 Earnings Release

Related indices

Russell 2000

More about the company